Clinical trial
Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as…
NCT00112697 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00112697 |
|---|---|
| Title | Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery |
| Official title | Randomized Phase II Trial Evaluating [Radiotherapy-Docetaxel-5 Fluorouracil] Association Versus [Radiotherapy-Docetaxel-Cisplatin] Association in Non Resecables First Line of Chemotherapy in Metastatics Pancreas Cancers Patients |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Radiation |
| Interventions | cisplatin, docetaxel, fluorouracil, radiation therapy |
| Enrollment | 71 |
| Start date | Oct 6, 2003 |
| Primary completion | Aug 1, 2008 |
| Completion | Mar 1, 2012 |
| First posted | Jun 3, 2005 |
| Last update posted | Feb 17, 2021 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: